Lee S. Schwartzberg, MD, FACP, discusses the utilization of genomics in cancer care.
Lee S. Schwartzberg, MD, FACP, West Cancer Center & Research Institute
Advertisement
Articles by Lee S. Schwartzberg, MD, FACP, West Cancer Center & Research Institute
Advertisement
Latest Updated Articles
Gaps in Treatment for HER2+ MBC With Brain MetastasisPublished: August 10th 2021 | Updated:
Subcutaneous Therapy for HER2+ Breast CancerPublished: July 20th 2021 | Updated:
Updates in HER2+ MBC: The NALA and SOPHIA TrialsPublished: July 13th 2021 | Updated:
Individualized Treatment Decisions for HER2+ Breast CancerPublished: July 27th 2021 | Updated:
Relapsed/Refractory HER2+ MBC Treatment DecisionsPublished: July 27th 2021 | Updated:
Treatment Options for HER2+ MBC With Brain MetastasisPublished: August 3rd 2021 | Updated:
Advertisement
Advertisement
Trending on OncLive
1
Long-Term Cilta-Cel Data Show Low Rates of PFS Events in Standard-Risk R/R Myeloma
2
Nonresponse to Bridging Therapy and Peak ALC After Cilta-Cel Are Associated With Neurotoxicity, NRM in Myeloma
3
FDA Updates Axi-Cel Label to Remove Limitation of Use in R/R PCNSL
4
FDA Underscores Risks Associated With DPD Deficiency and Capecitabine/5-FU Use in Cancer Care
5